MEDICAL BIO WARFARE DEFENSE PLAN 18 MAR 91

File: 970107_sep96_decls57_0002.txt
Page: 0002
Total Pages: 10

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  18 MAR 91                     

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          1

Folder Seq  #:         25



                                  UNCLASSIFIED


         DASG-HCD-D
         SUBJECT: Medical Biological Warfare (BW) Defense Plan (U)


             h. (U) Establish the Joint Medical Biological Warfare Defense
         Committee (JMBWDC) to monitor requirements for and stocks of
         vaccines, antitoxins, and immune globulins. This committee will
         make decisions on vaccination of U.S. Forces against BW agents.
             C. (U) Immunize the services' designated early deploying
         forces during peacetime against specific BW agents to maximize
         readiness and deployment posture. Amend immunization regulation.

             d. (U) Decentralize storage of vaccines, antitoxin, and immune
         globulin for security purposes.

             e. (U) Store vaccines in bulk to extend shelf-life to greater
         than ten years to minimize fiscal impact while maximizing BW
         defensive capabilities.

             f. (U) Maintain industrial base for vaccine and antitoxin
         production by establishing annual requirements in 5b. Also
         maintain CONUS industrial base for ciprofloxacin and doxycycline
         antibiotic production to ensure treatment capability against
         anthrax.

             g. (U) Finalize the TRADOC boarding process for the Theater
         Army Medical Laboratory. This laboratory was specifically designed
         to identify BW and chemical warfare agents used against U.S. Forces
         in the theater of operations.

             h.                                               Defense and
                 = Establish a MOIT betwp-pn r)on;%rtment of
        ff.to   @ll                                exchange suspected BW
         samples tor double verification of BW attack on either country's
         forces. This would provide solid evidence and an irrefutable basis
         for retaliation against opposing force(s) using BW agents.

             i. (U) Make vaccines and antitoxins available to select allies
y Sales to avoid future geopolitical issues.

         6. (U) Point of contact for this action is MAJ Robert Eng,
         DASG-HCD-D, 756-8163.

         FOR THE SURGEON GENERAL:




         Encl                             BRUCE T. MIKETINAC
                                          Brigadier General, MS
                                          Director, Health Care Operations

                                             2



                                               1 ru
                                  U   C'LA S S's F i, r-'-@

Document 10 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 18 mar 91:01029715474558
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 18 MAR 91
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997